These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 16547495

  • 1. B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis.
    Boisvert-Adamo K, Aplin AE.
    Oncogene; 2006 Aug 10; 25(35):4848-56. PubMed ID: 16547495
    [Abstract] [Full Text] [Related]

  • 2. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.
    Invest Ophthalmol Vis Sci; 2010 Jan 10; 51(1):421-9. PubMed ID: 19661225
    [Abstract] [Full Text] [Related]

  • 3. Mutant B-RAF mediates resistance to anoikis via Bad and Bim.
    Boisvert-Adamo K, Aplin AE.
    Oncogene; 2008 May 22; 27(23):3301-12. PubMed ID: 18246127
    [Abstract] [Full Text] [Related]

  • 4. Dual inhibition of (V600E)BRAF and the PI3K/AKT/mTOR pathway cooperates to induce apoptosis in melanoma cells through a MEK-independent mechanism.
    Sánchez-Hernández I, Baquero P, Calleros L, Chiloeches A.
    Cancer Lett; 2012 Jan 28; 314(2):244-55. PubMed ID: 22056813
    [Abstract] [Full Text] [Related]

  • 5. Cell-cell contacts prevent anoikis in primary human colonic epithelial cells.
    Hofmann C, Obermeier F, Artinger M, Hausmann M, Falk W, Schoelmerich J, Rogler G, Grossmann J.
    Gastroenterology; 2007 Feb 28; 132(2):587-600. PubMed ID: 17258732
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
    Duca L, Lambert E, Debret R, Rothhut B, Blanchevoye C, Delacoux F, Hornebeck W, Martiny L, Debelle L.
    Mol Pharmacol; 2005 Apr 28; 67(4):1315-24. PubMed ID: 15653554
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Akt and RhoA inhibition promotes anoikis of aggregated B16F10 melanoma cells.
    Goundiam O, Nagel MD, Vayssade M.
    Cell Biol Int; 2012 Mar 01; 36(3):311-9. PubMed ID: 22070397
    [Abstract] [Full Text] [Related]

  • 11. BCR/ABL and IL-3 activate Rap1 to stimulate the B-Raf/MEK/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion.
    Jin A, Kurosu T, Tsuji K, Mizuchi D, Arai A, Fujita H, Hattori M, Minato N, Miura O.
    Oncogene; 2006 Jul 20; 25(31):4332-40. PubMed ID: 16518411
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Growth factors rescue cutaneous melanoma cells from apoptosis induced by knockdown of mutated (V 600 E) B-RAF.
    Christensen C, Guldberg P.
    Oncogene; 2005 Sep 15; 24(41):6292-302. PubMed ID: 16007203
    [Abstract] [Full Text] [Related]

  • 14. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
    Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.
    Invest Ophthalmol Vis Sci; 2008 Jun 15; 49(6):2348-56. PubMed ID: 18281615
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
    Bhatt KV, Hu R, Spofford LS, Aplin AE.
    Oncogene; 2007 Feb 15; 26(7):1056-66. PubMed ID: 16924241
    [Abstract] [Full Text] [Related]

  • 19. Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.
    Tanami H, Imoto I, Hirasawa A, Yuki Y, Sonoda I, Inoue J, Yasui K, Misawa-Furihata A, Kawakami Y, Inazawa J.
    Oncogene; 2004 Nov 18; 23(54):8796-804. PubMed ID: 15467732
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.